In this issue:
Efficacy of risdiplam in infants with type 1 SMA
Genetic propensity for ICH progression after TBI
Plasma NfL levels in adults with Down syndrome
Subcutaneous foslevodopa/foscarbidopa for Parkinson disease
Contralateral sensory and pain perception in patients with unilateral neuropathy
Pathogenic impact of TP73 gene variants in people with ALS
Stroke prediction based on the spontaneous nystagmus suppression test
Botulinum toxin type A in hereditary spastic paraplegias
Small vessel disease burden and ICH in patients taking oral anticoagulants
Use of MID to ascertain responder status in patients with CIDP
Please login below to download this issue (PDF)